Back to today’s briefing

Story perspectives

China Emerges as AI Drug Discovery Rival to US

1/20/2026

24 3

Summary

Story summary

Leung Chuen-yan, a private equity investor, says China is becoming a major competitor to the United States in AI-driven drug discovery.
He notes success depends on computing power and data mining, including genomic and clinical trial data.
Chinese biotech firms collaborate with global pharmaceutical companies to bring their drugs to international markets.

1 of 1

Story summary

Leung Chuen-yan, a private equity investor, says China is becoming a major competitor to the United States in AI-driven drug discovery.
He notes success depends on computing power and data mining, including genomic and clinical trial data.
Chinese biotech firms collaborate with global pharmaceutical companies to bring their drugs to international markets.